1Schoell WM, Pieber D, Deich O, et al. Tumor angiogenesis as a prognostic factor in ovarian carcinoma:quantification of endothelial immunoreactivity by image analysis. Cancer, 1997,80:2257-2262.
4Takahashi R, Tanaka S, Kitadai Y, et al. Expression of vascular endothelial growth factor and angiogenesis in gastrointestinal stromal tumor of the stomach. Oncology ,2003,64:266-274.
5Fletcher CD, Berman J J, Corless C, et al. Diagnosis of gastrointestinal stromal tumors :a consensus approach. Int J Surg Pathol,2002,10:81- 89.
7De Giorgi U, Pupi A, Turrisi G, et al. Critical update and emerging trends in imatinib treatment for gastrointestinal stromal tumor. Rev Recent Clin Trials,2007,2:43-48.
8Edelman MJ. An update on the role of epidermal growth factor receptor inhibitors in non-small cell lung cancer. Semin Oncol,2005,32:3- 8.
9Lopes LF, Ojopi EB, Bacchi CE. Gastrointestinal stromal tumor in Brazil: clinicopathology, immunohistochemistry, and molecular genetics of 513 cases. Pathol Int ,2008,58:344-352.
10Miettinen M, Sobin L H, Lasota J. Gastrointestinal stromal tumors of the stomach : a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up[J]. Am J Surg Pathol, 2005,29(1 ):52-68.
